المؤلفون: Swanson, PA, Padilla, M, Hoyland, W, McGlinchey, K, Fields, PA, Bibi, S, Faust, SN, McDermott, AB, Lambe, T, Pollard, AJ, Durham, NM, Kelly, EJ, AstraZeneca/Oxford/VRC Study Group, Adlou, S, Aley, PK, Angus, B, Anslow, R, Baker, P, Bansal, H, Beveridge, A, Bridges-Webb, A, Ching, S, Cicconi, P, Clutterbuck, EA, Collins, AM, Darton, TC, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Ewer, KJ, Felle, S, Ferreira, DM, Folegatti, PM, Fuskova, M, Gaudinski, M, Gilbert, SC, Goodman, AL, Gordon, I, Green, CA, Harbolick, E, Hayes, S, Hill, AVS, Hill, H, Jenkin, D, Jepson, BM, Kasanyinga, M, Libri, V, Lillie, PJ, McGregor, AC, Minassian, AM, Mujadidi, YF, Novik, L, Payne, R, Pilataxi, F, Plested, E, Provstgaard-Morys, S, Ramasamy, M, Robinson, H, Sanders, K, Smith, A, Snape, MD, Song, R, Sutherland, RK, Thomson, EC, Toshner, M, Turner, DPJ, Voysey, M, Widge, AT, Williams, CJ

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::993e6e80c4502ef8c2b6b487068309ee
https://eprints.whiterose.ac.uk/178925/1/scitranslmed.abj7211.pdf

المؤلفون: Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ, Voysey, M, Adlou, S, Allen, L, Angus, B, Anslow, R, Asselin, M-C, Baker, N, Baker, P, Barlow, T, Beveridge, A, Bewley, KR, Brown, P, Brunt, E, Buttigieg, KR, Camara, S, Charlton, S, Chiplin, E, Cicconi, P, Clutterbuck, EA, Collins, AM, Coombes, NS, Clemens, SAC, Davison, M, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Emary, KRW, Ewer, KJ, Felle, S, Ferreira, DM, Finn, A, Folegatti, PM, Fothergill, R, Fraser, S, Garlant, H, Gatcombe, L, Godwin, KJ, Goodman, AL, Green, CA, Hallis, B, Hart, TC, Heath, PT, Hill, H, Hill, AVS, Jenkin, D, Kasanyinga, M, Kerridge, S, Knight, C, Leung, S, Libri, V, Lillie, PJ, Marinou, S, McGlashan, J, McGregor, AC, McInroy, L, Minassian, AM, Mujadidi, YF, Penn, EJ, Petropoulos, CJ, Pollock, KM, Proud, PC, Provstgaard-Morys, S, Rajapaska, D, Ramasamy, MN, Sanders, K, Shaik, I, Singh, N, Smith, A, Snape, MD, Song, R, Shrestha, S, Sutherland, RK, Thomson, EC, Turner, DPJ, Webb-Bridges, A, Wrin, T, Williams, CJ

المساهمون: Group, Oxford COVID Vaccine Trial

المصدر: Nature Medicine

مصطلحات موضوعية: Male, Antibodies, Viral, Neutralization, Cohort Studies, Multiplex, Asymptomatic Infections, 11 Medical and Health Sciences, Aged, 80 and over, Vaccines, biology, medicine.diagnostic_test, Vaccination, General Medicine, Middle Aged, Titer, Treatment Outcome, Infectious diseases, Female, Antibody, medicine.symptom, Adult, medicine.medical_specialty, COVID-19 Vaccines, Coronavirus disease 2019 (COVID-19), Adolescent, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunology, Immunization, Secondary, Asymptomatic, General Biochemistry, Genetics and Molecular Biology, World health, Article, Young Adult, Immune system, Statistical significance, Internal medicine, medicine, Humans, Aged, Infection Control, business.industry, SARS-CoV-2, Patient Acuity, COVID-19, Vaccine efficacy, Antibodies, Neutralizing, United Kingdom, Immunity, Humoral, Immunoassay, biology.protein, business

وصف الملف: text

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4f2fd5f45e6c2c0e1c1d6865f6d232
https://pubmed.ncbi.nlm.nih.gov/34588689

المؤلفون: Folegatti, PM, Harrison, K, Lopez, KR, Tilley, MW, Lopez-Camacho, C, Kim, YC, Preciado-Llanes, L, Rossi, SL, Poulton, I, Jenkin, D, Datoo, M, Themistocleous, Y, Lawrie, A, Roberts, R, Ewer, K, Berrie, E, Hill, A, Reyes-Sandoval, A

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1064::9ff9e00c9b540c24efac4a6e902d08a5
https://doi.org/10.4269/ajtmh.abstract2019

المؤلفون: Coughlan, L, Sridhar, S, Payne, R, Edmans, E, Milicic, A, Venkatraman, N, Lugonja, B, Clifton, L, Qi, C, McMichael, A, Folegatti, PM, Lawrie, AM, Roberts, R, de Graaf, H, Sukhtankar, P, Faust, SN, Lewis, DJM, Lambe, T, Hill, AVS, Gilbert, SC

المصدر: EBioMedicine, Vol 29, Iss, Pp 146-154 (2018)
EBioMedicine

مصطلحات موضوعية: 0301 basic medicine, Viral vectors, Cellular immunity, Heterologous, lcsh:Medicine, General Biochemistry, Genetics and Molecular Biology, Virus, Viral vector, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Immune system, Medicine, Adults, 030212 general & internal medicine, lcsh:R5-920, business.industry, Immunogenicity, lcsh:R, General Medicine, Virology, Influenza, 3. Good health, Vaccination, 030104 developmental biology, Influenza vaccines, chemistry, Older adults, T-cell responses, Vaccinia, business, lcsh:Medicine (General), Research Paper

وصف الملف: application/pdf; text

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5983940aa775dfd7965f632eb46586
http://www.sciencedirect.com/science/article/pii/S2352396418300653

المؤلفون: Venkatraman, N, Bowyer, G, Edwards, NJ, Griffiths, O, Powlson, J, Silman, D, Morter, R, Folegatti, PM, Minassian, AM, Poulton, ID, Collins, K, Brod, F, Angell-Manning, P, Berrie, E, Brendish, N, Glenn, G, Fries, L, Baum, J, Blagborough, AM, Roberts, R, Lawrie, AM, Lewis, DJ, Faust, SN, Gilbert, S, Ewer, KJ, Hill, AV

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1064::cdeff7a19e2b23f37f8e072d98cfab76
https://ora.ox.ac.uk/objects/uuid:e433efac-8e80-4278-b303-3537df06b9f7

المؤلفون: Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Wright D; The Jenner Institute, University of Oxford, Oxford, UK; Department of Paediatrics, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Platt A; The Jenner Institute, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, University of Oxford, Oxford, UK., Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK., Tran N; The Jenner Institute, University of Oxford, Oxford, UK., Boyd A; The Jenner Institute, University of Oxford, Oxford, UK., Turner C; The Jenner Institute, University of Oxford, Oxford, UK., Gitonga JN; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Karanja HK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Mugo D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK., Bowden TA; Wellcome Centre for Human Genetics, Division of Structural Biology, University of Oxford, Oxford, UK., Gilbert SC; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK; Pandemic Sciences Institute, University of Oxford, Oxford, UK., Charleston B; The Pirbright Institute, Pirbright, UK., Kaleebu P; Medical Research Council-Uganda Virus Research Institute and The London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK., Warimwe GM; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya. Electronic address: gwarimwe@kemri-wellcome.org.

المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Aug; Vol. 23 (8), pp. 956-964. Date of Electronic Publication: 2023 Apr 13.

نوع المنشور: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Rift Valley Fever*/prevention & control , Viral Vaccines*, Humans ; Adult ; Male ; Female ; Animals ; Antibodies, Neutralizing ; Glycoproteins ; United Kingdom ; Immunogenicity, Vaccine ; Antibodies, Viral ; Double-Blind Method

المؤلفون: Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Flaxman A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aboagye J; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Bittaye M; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cappuccini F; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Charlton S; Public Health England, Porton Down, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Davies S; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Edwards NJ; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fowler J; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbride C; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Godfrey L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Hallis B; Public Health England, Porton Down, UK., Humphries HE; Public Health England, Porton Down, UK., Jenkin D; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Sanders H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Thomas KM; Public Health England, Porton Down, UK., Ulaszewska M; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, UK., Woods D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Wright D; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.

المصدر: Clinical and experimental immunology [Clin Exp Immunol] 2023 Mar 24; Vol. 211 (3), pp. 280-287.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE

مواضيع طبية MeSH: ChAdOx1 nCoV-19* , Immunoglobulin G*, Humans ; Follow-Up Studies ; Randomized Controlled Trials as Topic ; Immunity ; Antibodies, Viral ; Vaccination

المؤلفون: Salkeld J; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Themistocleous Y; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Barrett JR; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Mitton CH; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Rawlinson TA; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Payne RO; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Hou MM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Khozoee B; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Edwards NJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Nielsen CM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Sandoval DM; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Bach FA; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Nahrendorf W; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom., Ramon RL; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Baker M; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ramos-Lopez F; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Quinkert D; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ellis KJ; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Poulton ID; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Lawrie AM; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Cho JS; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Nugent FL; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Spence PJ; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom., Silk SE; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom., Minassian AM; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom.

المصدر: Frontiers in immunology [Front Immunol] 2022 Aug 22; Vol. 13, pp. 984323. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022).

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Malaria* , Malaria, Falciparum* , Parasites*, Adult ; Animals ; Humans ; Plasmodium falciparum ; United Kingdom

المؤلفون: Folegatti PM; University of Oxford, Oxford, United Kingdom., Jenkin D; University of Oxford, Oxford, United Kingdom., Morris S; University of Oxford, Oxford, United Kingdom., Gilbert S; University of Oxford, Oxford, United Kingdom., Kim D; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Robertson JS; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Smith ER; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org., Martin E; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Gurwith M; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA., Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.

مؤلفون مشاركون: Benefit-Risk Assessment of VAccines by TechnolOgy Working Group BRAVATO, ex-V3SWG)

المصدر: Vaccine [Vaccine] 2022 Aug 19; Vol. 40 (35), pp. 5248-5262. Date of Electronic Publication: 2022 Jun 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Adenoviruses, Simian*/genetics , COVID-19*/prevention & control , COVID-19 Vaccines*/adverse effects , Zika Virus* , Zika Virus Infection*, Humans ; Male ; Risk Assessment ; SARS-CoV-2/genetics

المؤلفون: Ratcliff J; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Al-Beidh F; Imperial College London, London, United Kingdom.; Imperial College Health NHS Trust, St. Mary's Hospital, London, United Kingdom., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Bonsall D; Big Data Institute, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Costa Clemens SA; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Institute for Global Health, University of Siena, Siena, Italy., Estcourt L; Haematology Theme, Radcliffe Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom., Evans A; Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom., Fish M; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Folegatti PM; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Gordon AC; Imperial College London, London, United Kingdom.; Imperial College Health NHS Trust, St. Mary's Hospital, London, United Kingdom., Jay C; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Jennings A; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Laing E; Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom., Lambe T; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxfordgrid.4991.5, Oxford, United Kingdom., MacIntyre-Cockett G; Big Data Institute, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Menon D; University Division of Anaesthesia, University of Cambridgegrid.5335.0, Cambridge, United Kingdom., Mouncey PR; Intensive Care National Audit and Research Centre, London, United Kingdom., Nguyen D; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Roberts DJ; Haematology Theme, Radcliffe Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Clinical, Research, and Development, NHS Blood and Transport, Oxford, United Kingdom., Rowan KM; Intensive Care National Audit and Research Centre, London, United Kingdom., Rynne J; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Shankar-Hari M; School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom.; Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom.; Centre for Inflammation Research, The University of Edinburghgrid.4305.2, Edinburgh, United Kingdom., Williams S; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Harvala H; Microbiology Services, NHS Blood and Transport, London, United Kingdom., Golubchik T; Big Data Institute, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Simmonds P; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxfordgrid.4991.5, Oxford, United Kingdom.

مؤلفون مشاركون: AMPHEUS Project, REMAP-CAP Immunoglobulin Domain UK Investigators, and Oxford COVID-19 Vaccine Trial Group

المصدر: Journal of clinical microbiology [J Clin Microbiol] 2022 Apr 20; Vol. 60 (4), pp. e0228321. Date of Electronic Publication: 2022 Mar 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/diagnosis , SARS-CoV-2*/genetics, Alleles ; Humans ; Polymerase Chain Reaction

SCR Organism: SARS-CoV-2 variants